ES2632808T3 - Compuestos de carnosina donadores de óxido nítrico - Google Patents

Compuestos de carnosina donadores de óxido nítrico Download PDF

Info

Publication number
ES2632808T3
ES2632808T3 ES14183478.8T ES14183478T ES2632808T3 ES 2632808 T3 ES2632808 T3 ES 2632808T3 ES 14183478 T ES14183478 T ES 14183478T ES 2632808 T3 ES2632808 T3 ES 2632808T3
Authority
ES
Spain
Prior art keywords
compound
nitrooxy
formula
imidazol
carnosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14183478.8T
Other languages
English (en)
Spanish (es)
Inventor
Nicoletta Almirante
Laura Storoni
Elena Bastia
Stefania Brambilla
Sergio Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox Science Ireland Ltd
Original Assignee
Nicox Science Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Science Ireland Ltd filed Critical Nicox Science Ireland Ltd
Application granted granted Critical
Publication of ES2632808T3 publication Critical patent/ES2632808T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES14183478.8T 2014-09-04 2014-09-04 Compuestos de carnosina donadores de óxido nítrico Active ES2632808T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14183478.8A EP2993172B1 (en) 2014-09-04 2014-09-04 Nitric oxide donating carnosine compounds

Publications (1)

Publication Number Publication Date
ES2632808T3 true ES2632808T3 (es) 2017-09-15

Family

ID=51483284

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14183478.8T Active ES2632808T3 (es) 2014-09-04 2014-09-04 Compuestos de carnosina donadores de óxido nítrico

Country Status (7)

Country Link
US (1) US10093696B2 (enExample)
EP (1) EP2993172B1 (enExample)
JP (1) JP6616403B2 (enExample)
CN (1) CN106795122B (enExample)
CA (1) CA2959795C (enExample)
ES (1) ES2632808T3 (enExample)
WO (1) WO2016034619A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112566670B (zh) 2018-08-06 2024-11-12 尼科斯股份有限公司 一氧化氮释放第5型磷酸二酯酶抑制剂
CN111217834B (zh) * 2020-02-21 2021-10-26 维眸生物科技（上海）有限公司 Rock激酶抑制剂的硝基氧衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60149521A (ja) 1984-01-18 1985-08-07 Eisai Co Ltd 高眼圧・緑内障治療・予防用点眼剤
IT1270905B (it) 1993-10-15 1997-05-13 Bruschettini Srl Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
US20020168424A1 (en) 2002-07-31 2002-11-14 Dr. Mohsen Shahinpoor Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
US7795203B2 (en) * 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
ES2604562T3 (es) 2007-02-05 2017-03-07 Nicox Science Ireland Compuestos donantes de óxido nítrico
DE102007007029A1 (de) * 2007-02-08 2008-08-14 Bundesdruckerei Gmbh Sicherheits- und/oder Wertdokument mit photonischem Kristall

Also Published As

Publication number Publication date
US10093696B2 (en) 2018-10-09
US20170291920A1 (en) 2017-10-12
CN106795122A (zh) 2017-05-31
CN106795122B (zh) 2019-09-27
EP2993172B1 (en) 2017-04-19
WO2016034619A1 (en) 2016-03-10
JP6616403B2 (ja) 2019-12-04
JP2017525735A (ja) 2017-09-07
CA2959795A1 (en) 2016-03-10
CA2959795C (en) 2022-11-29
EP2993172A1 (en) 2016-03-09

Similar Documents

Publication Publication Date Title
ES2767136T3 (es) Derivados de prostaglandinas
ES2711363T3 (es) Derivados de (2-ureidoacetamido)alquilo como moduladores del receptor 2 de péptidos formilados
AU2019319004B2 (en) Nitric oxide releasing phosphodiesterase type 5 inhibitor
ES2708571T3 (es) Derivados de aminoácidos sustituidos con N-urea como moduladores del receptor de péptido formilado
WO2008071421A1 (en) Nitrate esters of carbonic anhydrase inhibitors
CN104994845B (zh) 用于眼科应用的醌基一氧化氮供体化合物
ES2663026T3 (es) Composiciones oftálmicas que contienen un donante de óxido nítrico
US10093696B2 (en) Nitric oxide donating carnosine compounds
CN111606852B (zh) 一种一氧化氮供体型Netarsudil衍生物及其制备方法和用途
CN105263487B (zh) 用于眼科应用的醌基一氧化氮供体化合物
ES2279100T3 (es) Derivados de quinolina.
US20110130375A1 (en) New no-releasing steroids for the treatment of retina and macula lutea diseases
HK1237769B (en) Nitric oxide donating carnosine compounds
HK1237769A1 (en) Nitric oxide donating carnosine compounds
JP2010513262A (ja) カルボニックアンヒドラーゼ阻害剤誘導体
ES2435554T3 (es) Compuestos de prostaglandina terapéuticos utilizados como agentes hipotensores oculares
WO2015155234A1 (en) Quinone based nitric oxide donating compounds
ES2348534T3 (es) Derivador de hidroximordolinona y uso medicinal del mismo.
Blangetti et al. Quinone based nitric oxide donating compounds
HK40049475B (en) Nitric oxide releasing phosphodiesterase type 5 inhibitor
HK1220371B (en) Quinone based nitric oxide donating compounds for ophthalmic use
HK1216505B (en) Quinone based nitric oxide donating compounds for ophthalmic use